Duopharma Biotech has expanded over the decades to support local healthcare alongside Malaysia’s development.
The Company’s formal history began with the establishment of Duopharma (M) Sendirian Berhad in 1978 and the incorporation of Duopharma Biotech in 2000. Today, as a leading publicly-traded Malaysian pharmaceutical company, Duopharma Biotech focuses on growing its portfolio in the Manufacturing, Research & Development and Commercialisation & Marketing of generic drugs and biosimilars, to deliver high quality, innovative and accessible solutions across Malaysia and the world over.

Establishment of Duopharma (M) Sendirian Berhad as a trading company

Listed on Bursa Malaysia

Chemical Company of Malaysia Berhad (CCMB) acquired Duopharma Biotech Berhad

Duopharma Biotech Berhad rebranded as CCM Duopharma Biotech Berhad (CCMD)

Restructuring of pharmaceutical companies under CCMD

Demerger of CCMD from CCMB

CCMD changed its name to Duopharma Biotech Berhad

Commercialisation of selected speciality products at HAPI Plant

Participated in the national vaccination programme on the provision of Covid-19 vaccines

Received first Halal-Certified Cancer Treatment

Establishment of PT Duopharma Healthcare Indonesia, a wholly-owned subsidiary of Duopharma Biotech Berhad